Freakonomics Radio
664. Are Thousands of Medical Cures Hiding in Plain Sight?
Feb 20, 2026
· 51m
Existing drugs can sometimes be repurposed to treat rare diseases. But making that match can be hard — and the financial incentives are weak. Guest host Steve Levitt tries to solve the puzzle. SOURCES: Chris Snyder , professor of economics at Dartmouth College. David Fajgenbaum , co-founder and president of Every Cure, physician-scientist at the University of Pennsylvania. Heather Stone , health science policy analyst at the Food & Drug Administration. Sarrin Chethik , senior policy analyst at the Market …
Buffering from publisher…
Audio streamed from the publisher — STT.ai does not host podcast files.
An kasa rubuta wannan sashe har yanzu
Yi amfani da STT.ai don rubuta wannan sashe tare da AI. Ka sami rubutu mai kyau tare da gano mai magana, da alamun lokaci, da fitarwa cikin sifofi da yawa.
@ action
@ action
@ action